Acro Biomedical Co., Ltd. (OTCPK: ACBM)
Health Care · Health Care Providers & Services · US
$—
— today · — 1Y
Acro Biomedical Co., Ltd. (OTCPK: ACBM) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.56M and employs 1 people.
trading between 0.02 and 0.10.
Tweenvest scores Acro Biomedical Co., Ltd. across four factors: quality 39/100. Its strongest factor is quality.
ACBM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.56M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- -2.31
- 52-week high
- $0.10
- 52-week low
- $0.02
- Avg volume (3M)
- —
- Shares outstanding
- 60.04M
- Employees
- 1
- Next earnings
- —
About Acro Biomedical Co., Ltd.
Acro Biomedical Co., Ltd. focuses on the development and commercialization of dietary supplements. The company offers products such as cordycepin and powdered cordyceps, which come from a type of fungus traditionally utilized in Chinese medicinal practices. Originally founded in 2014, the organization was known as Killer Waves Hawaii, Inc. until it rebranded as Acro Biomedical Co., Ltd. in January 2017. Its operations are headquartered in Fishers, Indiana.
- ISIN
- US0048921052
- Founded
- 2014
- Listed since
- Jan 8, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $355.98B | $397.87 | +0.32% |
| CVS Health CorporationNYSE: CVS | $118.82B | $93.10 | +0.22% |
| McKesson CorporationNYSE: MCK | $105.52B | $906.20 | +0.12% |
| HCA Healthcare, Inc.NYSE: HCA | $92.83B | $430.03 | +0.30% |
| Elevance Health, Inc.NYSE: ELV | $86.50B | $400.02 | +0.29% |
| The Cigna GroupNYSE: CI | $73.81B | $279.99 | +0.24% |
| Cencora, Inc.NYSE: COR | $62.60B | $328.06 | +1.33% |
| Cardinal Health, Inc.NYSE: CAH | $55.33B | $237.99 | +0.03% |
Figures last refreshed Aug 18, 2026.